This data is for informational purposes only. It is not medical advice. Always consult your transplant team for decisions about your care. Rankings show centers by highest survival rate and do not constitute a recommendation.
Pancreas Transplant Centers — Ranked by 1-Year Survival Rate
Centers with highest 1-year graft survival rate from SRTR November 2025. 0 centers reporting.
Note: Survival rate alone does not determine the best center for your situation. Centers that accept higher-risk patients or sicker patients may have lower survival rates. Discuss your options with your transplant team.
Data Insight
This ranking orders 0 pancreas transplant programs from the SRTR November 2025 Program-Specific Report cohort by risk-adjusted 1-year graft survival rate. Graft survival measures the estimated probability that a transplanted pancreas is still functioning 12 months after surgery. SRTR calculates these estimates using statistical models that adjust for recipient characteristics such as age, diagnosis, and medical history, so centers treating higher-risk patient populations are not penalized simply for accepting more complex cases.
Rankings like this one are useful as a starting point, but survival rate is not the only factor that matters when choosing a transplant center. Centers that accept sicker patients, run pediatric programs, or focus on difficult cases may report lower absolute survival while providing appropriate care. OPTN allocation rules also mean that geographic proximity to donor hospitals can affect wait times more than list position. SRTR excludes programs that fell below minimum case-volume thresholds, so some active pancreas programs are not ranked here. Reports update approximately twice yearly. This page reflects factual SRTR data and is not medical advice.
| Rank | Center | State | 1-yr Survival | 3-yr Survival | Transplants | Waitlist |
|---|
How to Read This Ranking
Survival rankings for pancreas transplantation reflect a single, well-defined outcome: the probability that the transplanted organ remains functional one year after surgery, adjusted for differences in patient mix. Two centers reporting the same raw survival number can sit very far apart in a risk-adjusted ranking when one accepts a much sicker waiting list than the other. SRTR's hierarchical Bayesian models lean toward the national average for low-volume centers, so a small program with five transplants in the cohort window will move less in either direction than a large program with five hundred — the ranking is most stable for centers in the middle of the volume distribution.
Risk adjustment matters because not every pancreas candidate carries the same baseline risk. Recipients with advanced disease, multiple prior failed transplants, donor-recipient size mismatches, or immunological sensitization will have lower expected survival before the procedure begins. SRTR's models subtract this expected survival from observed survival to produce a center-specific performance estimate. A center that consistently accepts the most complex referrals — for instance, regional referral hospitals taking patients other programs decline — can outperform on risk-adjusted survival while reporting lower raw numbers. The ranking column you see here is the adjusted figure, not the raw one.
Patients and referring clinicians use these rankings as one signal among several. Distance from home, insurance coverage, surgeon volume in your specific subtype, willingness to accept marginal donors, and program-specific eligibility criteria all weigh into a real-world transplant decision. The rankings here describe the typical outcome envelope a program has produced in the SRTR cohort window — they do not, and cannot, predict your individual outcome. Always discuss center selection with your transplant nephrologist, hepatologist, cardiologist, or pulmonologist, who can correlate published survival data with your specific clinical profile.
Caveats and Limitations
- SRTR Program-Specific Reports are released semi-annually (May and November). Rankings shown here reflect the most recent published cohort; some single-event changes at a program may not yet be visible.
- Programs below SRTR's minimum case-volume threshold are excluded from comparative rankings to preserve statistical reliability. Such programs may still be active and may report individual outcomes elsewhere.
- One-year graft survival is the SRTR's primary public outcome but not the only metric that matters. Patient survival, three-year graft survival, time to transplant from listing, and post-transplant readmission rates each tell a different story about program performance.
- Geographic concentration of transplant centers means a top-ranked program may be impractical for patients in rural or under-served regions. The Compare and State views allow filtering by geography to surface programs that are realistic options for a specific patient.
Data Sources
- SRTR Program-Specific Reports (November 2025 release) — risk-adjusted 1-year graft survival estimates for pancreas transplant programs. srtr.org
- OPTN pancreas allocation policy — policy governing pancreas distribution nationally. optn.transplant.hrsa.gov
About These Rankings
This data is for informational purposes only. It is not medical advice. Always consult your transplant team for decisions about your care. Rankings show centers by highest survival rate and do not constitute a recommendation.
Source: SRTR Program-Specific Reports, November 2025 SRTR Program-Specific Reports, November 2025 Centers are ranked by estimated 1-year graft survival probability for adult recipients. Centers without sufficient case volume are excluded per SRTR statistical methodology
Read our methodology — how this data is sourced, computed, and verified.